[Federal Register Volume 88, Number 135 (Monday, July 17, 2023)]
[Notices]
[Pages 45426-45427]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-15038]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with regulatory provisions, the Centers for 
Disease Control and Prevention (CDC) announces the following meeting of 
the Healthcare Infection Control Practices Advisory Committee (HICPAC). 
This is a virtual meeting. The public is welcomed to listen to the 
meeting via Zoom; 500 teleconference lines are available. Time will be 
available for public comment. Registration is required.

DATES: The meeting will be held on August 22, 2023, from 12 p.m. to 
2:30 p.m., EDT.

ADDRESSES: To register for this web conference, please go to: 
www.cdc.gov/hicpac. All registered participants will receive the 
meeting link and instructions shortly before the meeting. Please click 
the link below to join the webinar: https://cdc.zoomgov.com/j/1615322622?pwd=T1Vnci9IQVF6YS9nQzBzTTlTZTQzZz09.

Meeting ID: 161 532 2622
Passcode: 36073986

FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., HICPAC, Division 
of Healthcare Quality Promotion (DHQP), National Center for Emerging 
and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control 
and Prevention, l600 Clifton Road NE, Mailstop H16-3, Atlanta, Georgia 
30329. Telephone (404) 718-8039; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Committee is charged with providing advice and 
guidance to the Director, DHQP; the Director, NCEZID; the Director, 
CDC; and the Secretary, Department of Health and Human Services, 
regarding (1) the practice of healthcare infection prevention and 
control; (2) strategies for surveillance, prevention, and control of 
infections, antimicrobial resistance, and related events in settings 
where healthcare is provided; and (3) periodic updating of CDC 
guidelines and other policy statements regarding prevention of 
healthcare-associated infections and healthcare-related conditions.
    Matters to be Considered: The agenda will include the following 
updates: The Healthcare Personnel Guideline Workgroup; Isolation 
Precautions Guideline Workgroup; National Healthcare Safety Network 
Workgroup; and Dental Unit Waterlines Guideline Update. Agenda items 
are subject to change as priorities dictate.

Public Participation

    Oral Public Comment: Time will be available for public comment. 
Members of the public who wish to provide public comments should plan 
to attend the public comment session at the start time listed. Please 
note that the public comment period may end before the time indicated, 
following the last call for comments.
    Written Public Comment: The public may submit written comments in 
advance of the meeting. Comments should be submitted in writing by 
email to the contact person listed above. The deadline for receipt of 
written public comment is August 25, 2023. All

[[Page 45427]]

requests must contain the submitter's name, address, and organizational 
affiliation, as well as the topic being addressed. Written comments 
should not exceed one single-spaced typed page in length and delivered 
in 3 minutes or less. Written comments received in advance of the 
meeting will be included in the official record of the meeting.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-15038 Filed 7-14-23; 8:45 am]
BILLING CODE 4163-18-P